Insider Trading activities of Agios Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agios Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Agios Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Agios Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is AGIO. The reporting company's CIK number is 1439222.
The total value of stock buying since 2005 is $264,220,095.
The total value of stock sales since 2005 is $148,146,440.
The total value of stock option exercises since 2005 is $8,861,871.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Agios Pharmaceuticals Inc (AGIO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-07 0 $0 5,272 $448,377 5,272 $111,692
2018-06 0 $0 29,050 $2,752,411 29,050 $653,800
2018-05 0 $0 130,227 $11,651,451 130,227 $694,411
2018-04 0 $0 20,050 $1,581,594 20,050 $182,917
2018-03 200 $16,688 26,850 $2,194,687 30,987 $510,569
2018-02 0 $0 22,050 $1,728,790 24,250 $344,490
2018-01 851,154 $57,027,318 153,170 $11,751,773 153,170 $1,145,101
2017-12 0 $0 11,984 $729,465 54,941 $120,770
2017-11 0 $0 12,146 $770,413 8,146 $69,717
2017-10 0 $0 100,470 $7,029,040 86,000 $26,058
2017-09 0 $0 68,146 $4,482,790 49,146 $242,803
2017-08 0 $0 54,146 $3,225,357 29,146 $27,602
2017-07 0 $0 14,146 $778,730 5,146 $20,330
2017-06 0 $0 9,292 $487,850 13,292 $37,014
2017-05 0 $0 5,036 $246,064 3,000 $909
2017-04 3,122,875 $154,582,310 10,236 $577,002 5,146 $20,330
2017-03 0 $0 11,474 $613,631 9,438 $31,547
2017-02 0 $0 384,446 $19,071,227 6,000 $1,818
2016-11 0 $0 37,500 $2,412,500 27,500 $377,272
2016-10 0 $0 7,504 $397,545 0 $0
2016-09 0 $0 7,504 $385,403 0 $0
2016-08 0 $0 2,504 $93,424 0 $0
2016-07 0 $0 2,504 $107,158 0 $0
2016-06 0 $0 30,004 $1,892,354 42,700 $448,597
2016-05 0 $0 2,504 $129,431 0 $0
2016-04 0 $0 2,504 $133,813 0 $0
2016-03 0 $0 2,504 $93,110 0 $0
2016-02 0 $0 0 $0 10,000 $4,680
2016-01 0 $0 2,504 $107,484 113,999 $1,021,533
2015-12 0 $0 36,164 $2,053,216 5,500 $174,020
2015-11 0 $0 40,408 $2,580,175 31,000 $369,900
2015-10 0 $0 33,704 $2,335,336 24,000 $133,720
2015-09 0 $0 41,204 $3,533,322 46,356 $308,496
2015-08 0 $0 43,204 $4,200,921 53,500 $313,908
2015-07 0 $0 55,204 $6,336,988 45,500 $485,992
2015-06 0 $0 40,204 $4,599,001 42,800 $188,539
2015-05 0 $0 46,721 $5,163,867 12,171 $53,180
2015-04 0 $0 29,587 $2,963,664 0 $0
2015-03 0 $0 42,604 $4,423,064 15,500 $187,344
2015-02 0 $0 29,700 $3,292,914 42,829 $251,334
2015-01 0 $0 53,500 $5,889,280 4,500 $2,106
2014-12 230,451 $25,522,447 29,500 $2,862,385 4,500 $2,106
2014-11 0 $0 32,500 $2,655,575 14,000 $15,354
2014-10 0 $0 32,000 $1,922,240 8,500 $16,438
2014-09 0 $0 155,996 $8,542,123 113,241 $118,585
2014-08 0 $0 29,500 $1,188,524 21,500 $8,082
2014-07 0 $0 33,000 $1,535,160 8,000 $6,183
2014-06 2,300 $101,154 18,504 $719,876 6,504 $3,043
2014-05 0 $0 18,500 $800,914 9,500 $5,345
2014-04 297,050 $13,070,200 25,500 $1,006,490 55,500 $26,031
2014-03 0 $0 46,114 $1,760,046 225,114 $73,400
2014-02 0 $0 25,886 $752,526 25,886 $10,405
2014-01 0 $0 35,000 $1,155,959 35,000 $14,400
2013-07 772,221 $13,899,978 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Agios Pharmaceuticals Inc insiders (AGIO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-07-10 Bowden Christopher (Chief Medical Officer) Sale 2,000 86.84 173,680
2018-07-10 Bowden Christopher (Chief Medical Officer) Option Ex 2,000 35.16 70,320
2018-07-09 Alenson Carman (Principal Accounting Officer) Sale 272 84.94 23,103
2018-07-09 Alenson Carman (Principal Accounting Officer) Option Ex 272 52.29 14,222
2018-07-05 Biller Scott (Chief Scientific Officer) Sale 3,000 83.86 251,594
2018-07-05 Biller Scott (Chief Scientific Officer) Option Ex 3,000 9.05 27,150
2018-06-22 Hoerter Steven L. (Chief Commercial Officer) Sale 2,050 97.58 200,039
2018-06-22 Hoerter Steven L. (Chief Commercial Officer) Option Ex 2,050 39.76 81,508
2018-06-14 Foster-cheek Kaye I (Director) Sale 9,000 93.57 842,102
2018-06-14 Foster-cheek Kaye I (Director) Option Ex 9,000 50.73 456,570
2018-06-12 Bowden Christopher (Chief Medical Officer) Sale 2,000 93.11 186,210
2018-06-12 Bowden Christopher (Chief Medical Officer) Option Ex 2,000 35.16 70,320
2018-06-05 Biller Scott (Chief Scientific Officer) Sale 3,000 93.33 279,999
2018-06-05 Biller Scott (Chief Scientific Officer) Option Ex 3,000 9.05 27,150
2018-06-01 Schenkein David P (Chief Executive Officer) Sale 13,000 95.70 1,244,061
2018-06-01 Schenkein David P (Chief Executive Officer) Option Ex 13,000 1.40 18,252
2018-05-30 Schenkein David P (Chief Executive Officer) Sale 45,626 90.07 4,109,533
2018-05-30 Schenkein David P (Chief Executive Officer) Option Ex 45,626 .36 16,334
2018-05-23 Biller Scott (Chief Scientific Officer) Sale 15,177 90.00 1,365,930
2018-05-23 Biller Scott (Chief Scientific Officer) Option Ex 15,177 31.64 480,200
2018-05-23 Schenkein David P (Chief Executive Officer) Sale 49,374 91.25 4,505,229
2018-05-23 Schenkein David P (Chief Executive Officer) Option Ex 49,374 .30 14,960
2018-05-23 Hoerter Steven L. (Chief Commercial Officer) Sale 2,050 85.76 175,808
2018-05-23 Hoerter Steven L. (Chief Commercial Officer) Option Ex 2,050 39.76 81,508
2018-05-08 Bowden Christopher (Chief Medical Officer) Sale 2,000 81.38 162,760
2018-05-08 Bowden Christopher (Chief Medical Officer) Option Ex 2,000 35.16 70,320
2018-05-07 Biller Scott (Chief Scientific Officer) Sale 3,000 81.81 245,430
2018-05-07 Biller Scott (Chief Scientific Officer) Option Ex 3,000 9.05 27,150
2018-05-01 Schenkein David P (Chief Executive Officer) Sale 13,000 83.60 1,086,761
2018-05-01 Schenkein David P (Chief Executive Officer) Option Ex 13,000 .30 3,939
2018-04-23 Hoerter Steven L. (Chief Commercial Officer) Sale 2,050 85.95 176,197
2018-04-23 Hoerter Steven L. (Chief Commercial Officer) Option Ex 2,050 39.76 81,508
2018-04-12 Bowden Christopher (Chief Medical Officer) Sale 2,000 85.23 170,460
2018-04-12 Bowden Christopher (Chief Medical Officer) Option Ex 2,000 35.16 70,320
2018-04-05 Biller Scott (Chief Scientific Officer) Sale 3,000 75.57 226,709
2018-04-05 Biller Scott (Chief Scientific Officer) Option Ex 3,000 9.05 27,150
2018-04-02 Schenkein David P (Chief Executive Officer) Sale 13,000 77.56 1,008,228
2018-04-02 Schenkein David P (Chief Executive Officer) Option Ex 13,000 .30 3,939
2018-03-28 Biller Scott (Chief Scientific Officer) Option Ex 4,137 1.40 5,808
2018-03-22 Hoerter Steven L. (Chief Commercial Officer) Sale 2,050 84.65 173,532
2018-03-22 Hoerter Steven L. (Chief Commercial Officer) Option Ex 2,050 39.76 81,508
2018-03-19 Foster-cheek Kaye I (Director) Sale 6,800 81.97 557,396
2018-03-19 Foster-cheek Kaye I (Director) Option Ex 6,800 47.33 321,844
2018-03-16 Scadden David (Director) Buy 200 83.44 16,688
2018-03-14 Bowden Christopher (Chief Medical Officer) Sale 2,000 82.56 165,130
2018-03-14 Bowden Christopher (Chief Medical Officer) Option Ex 2,000 35.16 70,320
2018-03-05 Biller Scott (Chief Scientific Officer) Sale 3,000 82.57 247,709
2018-03-05 Biller Scott (Chief Scientific Officer) Option Ex 3,000 9.05 27,150
2018-03-01 Schenkein David P (Chief Executive Officer) Sale 13,000 80.84 1,050,920
2018-03-01 Schenkein David P (Chief Executive Officer) Option Ex 13,000 .30 3,939
2018-02-26 Foster-cheek Kaye I (Director) Option Ex 2,200 47.33 104,126
2018-02-22 Hoerter Steven L. (Chief Commercial Officer) Sale 2,050 78.63 161,191
2018-02-22 Hoerter Steven L. (Chief Commercial Officer) Option Ex 2,050 39.76 81,508
2018-02-16 Bowden Christopher (Chief Medical Officer) Sale 2,000 77.80 155,590
2018-02-16 Bowden Christopher (Chief Medical Officer) Option Ex 2,000 35.16 70,320
2018-02-05 Biller Scott (Chief Scientific Officer) Sale 3,000 76.34 229,035
2018-02-05 Biller Scott (Chief Scientific Officer) Option Ex 3,000 4.76 14,277
2018-02-01 Bowden Christopher (Chief Medical Officer) Sale 2,000 78.86 157,730
2018-02-01 Bowden Christopher (Chief Medical Officer) Option Ex 2,000 35.16 70,320
2018-02-01 Schenkein David P (Chief Executive Officer) Sale 13,000 78.86 1,025,244
2018-02-01 Schenkein David P (Chief Executive Officer) Option Ex 13,000 .30 3,939
2018-01-26 Schenkein David P (Chief Executive Officer) Sale 23,572 81.32 1,916,945
2018-01-26 Schenkein David P (Chief Executive Officer) Option Ex 23,572 .30 7,142
2018-01-24 Schenkein David P (Chief Executive Officer) Sale 13,553 80.01 1,084,375
2018-01-24 Schenkein David P (Chief Executive Officer) Option Ex 13,553 .30 4,106
2018-01-23 Schenkein David P (Chief Executive Officer) Sale 32,875 80.01 2,630,328
2018-01-23 Schenkein David P (Chief Executive Officer) Option Ex 32,875 .30 9,961
2018-01-23 Celgene European Investment Co Llc (10% Owner) Buy 851,154 67.00 57,027,318
2018-01-23 Hoerter Steven L. (Chief Commercial Officer) Sale 25,000 74.83 1,870,750
2018-01-23 Hoerter Steven L. (Chief Commercial Officer) Option Ex 25,000 39.76 994,000
2018-01-16 Schenkein David P (Chief Executive Officer) Sale 53,000 73.42 3,891,525
2018-01-16 Schenkein David P (Chief Executive Officer) Option Ex 53,000 .30 16,059
2018-01-12 Alenson Carman (Principal Accounting Officer) Sale 2,150 75.00 161,250
2018-01-12 Alenson Carman (Principal Accounting Officer) Option Ex 2,150 52.29 112,423
2018-01-10 Biller Scott (Chief Scientific Officer) Sale 3,000 65.00 195,000
2018-01-10 Biller Scott (Chief Scientific Officer) Option Ex 3,000 .47 1,404
2017-12-07 Cantley Lewis Clayton Jr. (Director) Sale 1,838 60.06 110,399
2017-12-06 Biller Scott (Chief Scientific Officer) Option Ex 46,795 1.09 51,053
2017-12-06 Cantley Lewis Clayton Jr. (Director) Sale 2,000 58.95 117,906
2017-12-01 Biller Scott (Chief Scientific Officer) Sale 2,146 60.76 130,390
2017-12-01 Biller Scott (Chief Scientific Officer) Option Ex 2,146 31.64 67,899
2017-12-01 Schenkein David P (Chief Executive Officer) Sale 6,000 61.80 370,770
2017-12-01 Schenkein David P (Chief Executive Officer) Option Ex 6,000 .30 1,818
2017-11-14 Cantley Lewis Clayton Jr. (Director) Sale 2,000 59.91 119,820
2017-11-13 Cantley Lewis Clayton Jr. (Director) Sale 2,000 62.07 124,140
2017-11-01 Biller Scott (Chief Scientific Officer) Sale 2,146 63.49 136,255
2017-11-01 Biller Scott (Chief Scientific Officer) Option Ex 2,146 31.64 67,899
2017-11-01 Schenkein David P (Chief Executive Officer) Sale 6,000 65.03 390,198
2017-11-01 Schenkein David P (Chief Executive Officer) Option Ex 6,000 .30 1,818
2017-10-17 Cantley Lewis Clayton Jr. (Director) Sale 2,000 71.10 142,200
2017-10-16 Cantley Lewis Clayton Jr. (Director) Sale 2,000 71.09 142,180
2017-10-04 Biller Scott (Chief Scientific Officer) Sale 10,470 70.00 732,900
2017-10-04 Schenkein David P (Chief Executive Officer) Sale 80,000 70.14 5,611,200
2017-10-04 Schenkein David P (Chief Executive Officer) Option Ex 80,000 .30 24,240
2017-10-02 Schenkein David P (Chief Executive Officer) Sale 6,000 66.76 400,560
2017-10-02 Schenkein David P (Chief Executive Officer) Option Ex 6,000 .30 1,818
2017-09-18 Schenkein David P (Chief Executive Officer) Sale 35,000 67.12 2,349,200
2017-09-18 Schenkein David P (Chief Executive Officer) Option Ex 35,000 .30 10,605
2017-09-14 Cantley Lewis Clayton Jr. (Director) Sale 2,000 65.71 131,420
2017-09-13 Cantley Lewis Clayton Jr. (Director) Sale 2,000 65.47 130,940
2017-09-11 Bowden Christopher (Chief Medical Officer) Sale 6,000 65.00 390,000
2017-09-11 Bowden Christopher (Chief Medical Officer) Option Ex 6,000 35.16 210,959
2017-09-11 Biller Scott (Chief Scientific Officer) Sale 15,000 65.00 975,000
2017-09-01 Biller Scott (Chief Scientific Officer) Sale 2,146 61.99 133,030
2017-09-01 Biller Scott (Chief Scientific Officer) Option Ex 2,146 9.05 19,421
2017-09-01 Schenkein David P (Chief Executive Officer) Sale 6,000 62.20 373,200
2017-09-01 Schenkein David P (Chief Executive Officer) Option Ex 6,000 .30 1,818
2017-08-23 Cantley Lewis Clayton Jr. (Director) Sale 2,000 57.08 114,160
2017-08-22 Cantley Lewis Clayton Jr. (Director) Sale 2,000 56.62 113,240
2017-08-02 Biller Scott (Chief Scientific Officer) Sale 21,000 60.06 1,261,260
2017-08-02 Schenkein David P (Chief Executive Officer) Sale 24,000 60.55 1,453,200
2017-08-02 Schenkein David P (Chief Executive Officer) Option Ex 24,000 .30 7,272
2017-08-01 Biller Scott (Chief Scientific Officer) Sale 2,146 55.05 118,137
2017-08-01 Biller Scott (Chief Scientific Officer) Option Ex 2,146 9.05 19,421
2017-08-01 Schenkein David P (Chief Executive Officer) Sale 3,000 55.12 165,360
2017-08-01 Schenkein David P (Chief Executive Officer) Option Ex 3,000 .30 909
2017-07-20 Cantley Lewis Clayton Jr. (Director) Sale 2,000 57.12 114,250
2017-07-19 Cantley Lewis Clayton Jr. (Director) Sale 7,000 56.13 392,910
2017-07-07 Biller Scott (Chief Scientific Officer) Sale 2,146 55.00 118,030
2017-07-07 Biller Scott (Chief Scientific Officer) Option Ex 2,146 9.05 19,421
2017-07-03 Schenkein David P (Chief Executive Officer) Sale 3,000 51.18 153,540
2017-07-03 Schenkein David P (Chief Executive Officer) Option Ex 3,000 .30 909
2017-06-23 Biller Scott (Chief Scientific Officer) Option Ex 3,000 .47 1,404
2017-06-21 Biller Scott (Chief Scientific Officer) Sale 4,292 55.00 236,060
2017-06-21 Biller Scott (Chief Scientific Officer) Option Ex 7,292 4.76 34,702
2017-06-14 Cantley Lewis Clayton Jr. (Director) Sale 1,000 51.09 51,090
2017-06-13 Cantley Lewis Clayton Jr. (Director) Sale 1,000 50.64 50,640
2017-06-07 Schenkein David P (Chief Executive Officer) Sale 1,900 50.02 95,038
2017-06-07 Schenkein David P (Chief Executive Officer) Option Ex 1,900 .30 575
2017-06-06 Schenkein David P (Chief Executive Officer) Sale 1,100 50.02 55,022
2017-06-06 Schenkein David P (Chief Executive Officer) Option Ex 1,100 .30 333
2017-05-25 Cantley Lewis Clayton Jr. (Director) Sale 1,018 46.92 47,764
2017-05-24 Cantley Lewis Clayton Jr. (Director) Sale 1,018 47.27 48,120
2017-05-01 Schenkein David P (Chief Executive Officer) Sale 3,000 50.06 150,180
2017-05-01 Schenkein David P (Chief Executive Officer) Option Ex 3,000 .30 909
2017-04-24 Celgene Corp /de/ (10% Owner) Buy 1,873,725 49.50 92,749,386
2017-04-18 Cantley Lewis Clayton Jr. (Director) Sale 1,018 50.92 51,836
2017-04-17 Cantley Lewis Clayton Jr. (Director) Sale 4,072 55.20 224,774
2017-04-03 Biller Scott (Chief Scientific Officer) Sale 2,146 58.03 124,532
2017-04-03 Biller Scott (Chief Scientific Officer) Option Ex 2,146 9.05 19,421
2017-04-03 Schenkein David P (Chief Executive Officer) Sale 3,000 58.62 175,860
2017-04-03 Schenkein David P (Chief Executive Officer) Option Ex 3,000 .30 909
2017-03-23 Cantley Lewis Clayton Jr. (Director) Sale 1,018 53.91 54,880
2017-03-22 Cantley Lewis Clayton Jr. (Director) Sale 1,018 52.31 53,251
2017-03-20 Biller Scott (Chief Scientific Officer) Sale 6,438 55.00 354,090
2017-03-20 Biller Scott (Chief Scientific Officer) Option Ex 6,438 4.76 30,638
2017-03-01 Schenkein David P (Chief Executive Officer) Sale 3,000 50.47 151,410
2017-03-01 Schenkein David P (Chief Executive Officer) Option Ex 3,000 .30 909
2017-02-28 Nelsen Robert (Director) Sale 47,859 49.82 2,384,431
2017-02-27 Nelsen Robert (Director) Sale 195,223 49.26 9,616,294
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of AGIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Agios Pharmaceuticals Inc (symbol AGIO, CIK number 1439222) see the Securities and Exchange Commission (SEC) website.